| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; 2 Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland; 3 Cancer Institute, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 4 Cancer Prevention Studies Branch, Center for Cancer Research, National Cancer Institute, Rockville, Maryland; 5 Center for Population Genomics, National Center for Toxicology Research, Food and Drug Administration, Jefferson, Arkansas; and 6 Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland
Linxian, a rural county in North Central China, has among the highest rates of esophageal squamous cell carcinoma (ESCC) and gastric cardia adenocarcinoma (GCA) in the world. Its inhabitants have documented chronic nutritional inadequacies, including folate and vitamin B12 deficiencies. Using a cohort we have been studying in Linxian since 1985, we examined the relationship between incident ESCC and GCA cancers and three polymorphisms in two genes that code for enzymes that require folate and B12 as cofactors: methionine synthase reductase (MTRR) A66G and methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C. We conducted a case-cohort study among 4005 individuals in our cohort who were alive and cancer free in 1991 and had blood samples adequate for DNA extraction. Polymorphisms were measured on all 219 incident cancers (129 ESCCs and 90 GCAs) that developed through May 1996 and on 398 controls. Cox proportional hazard models were used to estimate relative risks (RRs) and 95% confidence intervals (CIs). Individuals with the MTHFR 677TT genotype had significantly higher combined ESCC/GCA risks (RR, 1.45; 95% CI, 1.02–2.05) than those with CC or CT genotypes. The only subjects to have MTHFR 1298CC were three ESCC cases (P = 0.03). Compared with subjects with the MTRR 66AA genotype, subjects with the AG or GG genotypes had significantly higher risk of ESCC (RR, 1.59; 95% CI, 1.04–2.42). No association was observed for GCA. Our results suggest that the MTHFR C677T and MTRR A66G polymorphisms influence the risk of ESCC and GCA in this population.
This article has been cited by other articles:
|
|
 |
|
  S. Boccia, R. Hung, G. Ricciardi, F. Gianfagna, M. P. A. Ebert, J.-Y. Fang, C.-M. Gao, T. Gotze, F. Graziano, M. Lacasana-Navarro, et al. Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review Am. J. Epidemiol., March 1, 2008; 167(5): 505 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Vollset, J. Igland, M. Jenab, A. Fredriksen, K. Meyer, S. Eussen, H. K. Gjessing, P. M. Ueland, G. Pera, N. Sala, et al. The Association of Gastric Cancer Risk with Plasma Folate, Cobalamin, and Methylenetetrahydrofolate Reductase Polymorphisms in the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2416 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mahabir, C. C Abnet, Y.-L. Qiao, L. D Ratnasinghe, S. M Dawsey, Z.-W. Dong, P. R Taylor, and S. D Mark A prospective study of polymorphisms of DNA repair genes XRCC1, XPD23 and APE/ref-1 and risk of stroke in Linxian, China J. Epidemiol. Community Health, August 1, 2007; 61(8): 737 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wang, Q. Ke, W. Chen, J. Wang, Y. Tan, Y. Zhou, Z. Hua, W. Ding, J. Niu, J. Shen, et al. Polymorphisms of MTHFD, Plasma Homocysteine Levels, and Risk of Gastric Cancer in a High-Risk Chinese Population Clin. Cancer Res., April 15, 2007; 13(8): 2526 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. F. Zhang, M. B. Terry, L. Hou, J. Chen, J. Lissowska, M. Yeager, W. Zatonski, S. Chanock, A. Morabia, and W.-H. Chow Genetic Polymorphisms in Folate Metabolism and the Risk of Stomach Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 115 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Shrubsole, Y.-T. Gao, Q. Cai, X. O. Shu, Q. Dai, F. Jin, and W. Zheng MTR and MTRR Polymorphisms, Dietary Intake, and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 586 - 588. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Galeone, C. Pelucchi, F. Levi, E. Negri, R. Talamini, S. Franceschi, and C. La Vecchia Folate intake and squamous-cell carcinoma of the oesophagus in Italian and Swiss men Ann. Onc., March 1, 2006; 17(3): 521 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-X. Yang, K. Matsuo, H. Ito, M. Shinoda, S. Hatooka, K. Hirose, K. Wakai, T. Saito, T. Suzuki, T. Maeda, et al. Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan Carcinogenesis, July 1, 2005; 26(7): 1285 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Shi, Z. Zhang, G. Li, P. C. Pillow, L. M. Hernandez, M. R. Spitz, and Q. Wei Sex Differences in Risk of Lung Cancer Associated with Methylene-tetrahydrofolate Reductase Polymorphisms Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1477 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Savage, C. C. Abnet, K. Haque, S. D. Mark, Y.-L. Qiao, Z.-W. Dong, S. M. Dawsey, P. R. Taylor, and S. J. Chanock Polymorphisms in Interleukin -2, -6, and -10 Are Not Associated with Gastric Cardia or Esophageal Cancer in a High-Risk Chinese Population Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1547 - 1549. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
